Paul Mintz - 09 Dec 2025 Form 4/A - Amendment Insider Report for Nuo Therapeutics, Inc. (AURX)

Reporting relationship: Director
Issuer ticker: AURX
Reported as of: 09 Dec 2025
Net transaction value: -$0.2
SEC form: 4/A - Amendment
Accepted by SEC: 11 Dec 2025, 21:55:15 UTC
Original report date: 11 Dec 2025
Prior SEC filing: 04 Aug 2025
Next SEC filing: 02 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ David Jorden, attorney-in-fact

Key filing fact

Paul Mintz filed Form 4/A - Amendment for Nuo Therapeutics, Inc. (AURX) on 11 Dec 2025.

Key facts

This page summarizes Paul Mintz's Form 4/A - Amendment filing for Nuo Therapeutics, Inc. (AURX).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 11 Dec 2025, 21:55.

Change

Previous filing in this sequence was filed on 04 Aug 2025.
Current net transaction value: -$0.2.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001480208 Primary reporting owner

Mintz Paul

Relationship: Director
Address: C/O NUO THERAPEUTICS, INC., 8285 EL RIO, SUITE190, HOUSTON
Signature: /s/ David Jorden, attorney-in-fact
Signature date: 11 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AURX transaction

Common Stock

Options Exercise

Transaction value: $20,000
Shares: +50,000
Change %: +74%
Price: $0.4000
Shares after: 117,385
Date: 09 Dec 2025
Ownership: Direct

AURX transaction

Common Stock

Tax liability

Transaction value: $20,000
Shares: -9,091
Change %: -7.7%
Price: $2.20
Shares after: 108,294
Date: 09 Dec 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AURX transaction Derivative

Option to purchase common stock

Options Exercise

Transaction value: $0
Shares: -50,000
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 31 Dec 2018
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 50,000
Exercise price: $0.4000

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents a net exercise of outstanding stock options. The reporting person received 40,909 shares of common stock on the net exercise of option to purchase 50,000 shares of common stock. The issuer withheld 9,091 shares of common stock underlying the option for payment of the exercise price using the closing price of $2.20.